SAIF, Muhammad Wasif. MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas, [S. l.], v. 15, n. 3, p. 278–279, 2014. DOI: 10.6092/1590-8577/2507. Disponível em: https://serena.atcult.it/index.php/jop/article/view/2507. Acesso em: 8 may. 2025.